OGI's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.17 -- higher than only 4.16% of US-listed equities with positive expected earnings growth.
OGI's went public 1.35 years ago, making it older than just 1.31% of listed US stocks we're tracking.
Revenue growth over the past 12 months for Organigram Holdings Inc comes in at 554.28%, a number that bests 98.74% of the US stocks we're tracking.
If you're looking for stocks that are quantitatively similar to Organigram Holdings Inc, a group of peers worth examining would be MARA, DHIL, AQMS, RCON, and KRKR.
OGI's SEC filings can be seen here. And to visit Organigram Holdings Inc's official web site, go to www.organigram.ca.
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. Its products include strains, cannabis oils, and vaporizrs. The company was founded in 2013 and is headquartered in Moncton, Canada.
MONCTON, New Brunswick--(BUSINESS WIRE)---- $OGI--In an effort to continue to break down the barriers to purchasing from the legal cannabis market in Canada, and reinforce its ongoing commitment to value, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of SHRED, a high quality, high potency, affordable dried flower product pre-shredded for additional consum
Data from the Hyfire retail platform suggests OrganiGram Holdings Inc.’s (NASDAQ: OGI ) sales trends improved during the fiscal fourth quarter, with a significant acceleration last month. The OrganiGram Analyst: Cantor Fitzgerald's Pablo Zuanic maintained an overweight rating for OrganiGram, while raising the price target from C$5.00 to C$5.35. The OrganiGram Thesis: The Hyfire data implies the company’s recreational sales grew 12% sequentially in the August … Full story available on Benzinga.com